Unlock stock picks and a broker-level newsfeed that powers Wall Street.

NasdaqCM - Nasdaq Real Time Price USD

Gelteq Limited (GELS)

1.9000
-0.4200
(-18.10%)
At close: April 25 at 4:00:02 PM EDT
1.9001
+0.00
+(0.01%)
After hours: April 25 at 7:44:25 PM EDT
Currency in AUD All numbers in thousands
Download
Breakdown
TTM
6/30/2024
6/30/2023
6/30/2022
6/30/2021
Total Revenue
--
--
79.8430
147.5360
--
Cost of Revenue
--
--
48.9250
94.8740
--
Gross Profit
--
--
30.9180
52.6620
--
Operating Expense
2,774.4650
2,774.4650
3,410.5800
3,246.9360
647.6240
Operating Income
-2,774.4650
-2,774.4650
-3,379.6620
-3,194.2740
-647.6240
Net Non Operating Interest Income Expense
-600.2200
-600.2200
-404.0690
-175.6340
-1.2970
Other Income Expense
-171.5100
-171.5100
277.5110
1.0170
-8.7600
Pretax Income
-3,546.1950
-3,546.1950
-3,506.2200
-3,368.8910
-648.9210
Net Income Common Stockholders
-3,546.1950
-3,546.1950
-3,506.2200
-3,368.8910
-648.9210
Diluted NI Available to Com Stockholders
-3,546.1950
-3,546.1950
-3,506.2200
-3,368.8910
-648.9210
Basic EPS
-0.38
--
-0.37
-0.36
-0.07
Diluted EPS
-0.38
--
-0.37
-0.36
-0.07
Basic Average Shares
9,438.0750
--
9,438.0750
9,438.0750
9,438.0750
Diluted Average Shares
9,438.0750
--
9,438.0750
9,438.0750
9,438.0750
Total Operating Income as Reported
-2,945.9750
-2,945.9750
-3,102.1510
-3,193.2570
-647.6240
Total Expenses
2,774.4650
2,774.4650
3,459.5050
3,341.8100
647.6240
Net Income from Continuing & Discontinued Operation
-3,546.1950
-3,546.1950
-3,506.2200
-3,368.8910
-648.9210
Normalized Income
-3,374.6850
-3,374.6850
-3,783.7310
-3,369.9080
-648.9210
Interest Expense
585.1200
585.1200
403.5210
174.5030
1.2970
Net Interest Income
-600.2200
-600.2200
-404.0690
-175.6340
-1.2970
EBIT
-2,961.0750
-2,961.0750
-3,102.6990
-3,194.3880
-647.6240
EBITDA
-1,749.1790
-1,749.1790
-1,876.2080
-1,979.1280
-589.6790
Reconciled Cost of Revenue
--
--
48.9250
94.8740
--
Reconciled Depreciation
1,211.8960
1,211.8960
1,226.4910
1,215.2600
57.9450
Net Income from Continuing Operation Net Minority Interest
-3,546.1950
-3,546.1950
-3,506.2200
-3,368.8910
-648.9210
Total Unusual Items Excluding Goodwill
-171.5100
-171.5100
277.5110
1.0170
--
Total Unusual Items
-171.5100
-171.5100
277.5110
1.0170
--
Normalized EBITDA
-1,577.6690
-1,577.6690
-2,153.7190
-1,980.1450
-589.6790
6/30/2021 - 10/29/2024

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

SXTC China SXT Pharmaceuticals, Inc.
2.2900
+44.94%
 
SNOA Sonoma Pharmaceuticals, Inc.
4.2300
+9.59%
 
SBFM Sunshine Biopharma, Inc.
1.5100
-2.58%
 
UPC Universe Pharmaceuticals INC
4.2000
+10.53%
 
PTPI Petros Pharmaceuticals, Inc.
0.0540
+5.47%
 
IRWD Ironwood Pharmaceuticals, Inc.
0.8885
+1.12%
 
CGC Canopy Growth Corporation
1.4100
-5.37%
 
RGC Regencell Bioscience Holdings Limited
29.01
-1.39%
 
SHPH Shuttle Pharmaceuticals Holdings, Inc.
0.3100
+4.52%
 
ZYBT Zhengye Biotechnology Holding Limited
10.44
-1.04%